GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ansell Ltd (OTCPK:ANSLF) » Definitions » Days Sales Outstanding

Ansell (Ansell) Days Sales Outstanding : 51.82 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Ansell Days Sales Outstanding?

Ansell's average Accounts Receivable for the six months ended in Dec. 2023 was $223 Mil. Ansell's Revenue for the six months ended in Dec. 2023 was $785 Mil. Hence, Ansell's Days Sales Outstanding for the six months ended in Dec. 2023 was 51.82.

The historical rank and industry rank for Ansell's Days Sales Outstanding or its related term are showing as below:

ANSLF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.5   Med: 56.48   Max: 64.71
Current: 48.5

During the past 13 years, Ansell's highest Days Sales Outstanding was 64.71. The lowest was 48.50. And the median was 56.48.

ANSLF's Days Sales Outstanding is ranked better than
71.25% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.66 vs ANSLF: 48.50

Ansell's Days Sales Outstanding increased from Dec. 2022 (50.34) to Dec. 2023 (51.82).


Ansell Days Sales Outstanding Historical Data

The historical data trend for Ansell's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ansell Days Sales Outstanding Chart

Ansell Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.91 55.70 52.77 57.08 56.56

Ansell Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.57 47.47 50.34 49.30 51.82

Competitive Comparison of Ansell's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Ansell's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ansell's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ansell's Days Sales Outstanding falls into.



Ansell Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ansell's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

Days Sales Outstanding (A: Jun. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )*Days in Period
=( (265.4 + 247.5) / 2 ) / 1655.1*365
=256.45 / 1655.1*365
=56.56

Ansell's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (247.5 + 198.2) / 2 ) / 784.9*365 / 2
=222.85 / 784.9*365 / 2
=51.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ansell  (OTCPK:ANSLF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Ansell Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ansell's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Ansell (Ansell) Business Description

Traded in Other Exchanges
Address
678 Victoria Street, Level 3, Richmond, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.

Ansell (Ansell) Headlines

From GuruFocus

Australian Ansell Expanding Into Medical Supplies

By Holmes Osborne, CFA Holmes Osborne, CFA 02-15-2017

Ansell Growing Through M&A

By Holmes Osborne, CFA Holmes Osborne, CFA 02-22-2019

PPE Manufacturer Ansell Still Trading at a Nice Valuation

By Holmes Osborne, CFA Holmes Osborne, CFA 05-19-2021